As such, in this chapter we focus on the concept of multicomponent self-assembly as a biomimetic approach for developing hydrogel biomaterials for biomedical applications using various mixtures of building blocks of different molecular sizes (small-small molecules, small molecules-macromolecule, and macromolecules) and sources (amino acids, peptides, saccharides, and nucleobases).
Research on small molecules and small molecule drugs in regenerative medicine is currently increasing.
In this review, we discuss the potential applications of small molecules and small molecule drugs in regenerative medicine.
This knowledge environment includes freely available data derived from small molecules and small-molecule screens and resources for studying these data.
This is achieved by breaking the polymer backbone into smaller chain lengths, providing compatible, small molecules to plasticise the polymer.
It was difficult to detect small molecules directly using conventional surface plasmon resonance (SPR) biosensors since the changes of refractive index, which was resulted by binding small molecules, were usually small.
Our work not only starts new applications of SiO2@Au nanoshells in mass spectrometry, but also contributes to advanced analysis of either a group of small molecules or one target small molecule from complex bio-samples in a pre-designed manner for bio-diagnostics.
This is problematic in applications where the energy values are important, for example when placing small molecules in docking applications; the relatively small binding energy of the small molecule is drowned by the large energy due to atomic clashes that hampers finding the lowest energy state of the docked ligand.
Also, more is being understood about the exact molecular pathways that are involved in R.A., and treatments are being developed to target these using small molecules (pills or very small proteins).
Small molecules and hypoxia.
Small molecules, such as drugs, go unnoticed.
